Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Edinburg, Texas 78539


The goal of this study is to evaluate the impact of a comprehensive diabetes education and management program based on frequent communication with patients using teleconsultation, text messaging, and phone calls on diabetes related outcomes in Latino patients with type 2 diabetes. The investigators hypothesize that the decline in hemoglobin A1c value between the baseline and the six-month visit will be at least 0.5 percent greater in the intervention group than in the control group.

Study summary:

In this study participants will be followed for a period of 9 months. The control group will receive usual care during this period of time. While, the intervention group will be part of a diabetes education and management program lasting 6 months via a smartphone participants will receive. The 6 month intervention will be followed by a 3 month observation period.


Inclusion Criteria: - Have physician-diagnosed type 2 diabetes - Be self-identified as Hispanic or Latino - An A1c value between 8-14% within the last three months. - Demonstrate the ability, either alone or with the help of a family member that will be with the patient at least once a week, to use the technology that will be used during the teleconsultations Exclusion Criteria: - Severe diabetes related chronic complications such as chronic renal failure, blindness, amputations, stroke, etc. - Concomitant chronic illnesses that would affect their participation in the program, i.e. cancer, debilitating diseases, etc. - Any other condition that would affect participant's basic mental health skills - Type 1 diabetes or gestational diabetes - Patients with abnormal hemoglobin, anemia or any condition that may affect red blood cell turnover. Any of these conditions may be detected through participants' history or through the laboratory report at study screening - Signs or symptoms of metabolic decompensation (polyuria, polydypsia, polyphagia, unexplained weight loss, blurry vision, lethargy, etc.)



Primary Contact:

Principal Investigator
Sylvia E Rosas, MD
Joslin Diabetes Center

Backup Contact:


Location Contact:

Edinburg, Texas 78539
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.